Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients?

Pompili C, Absolom K, Franks K, Velikova G.

J Thorac Dis. 2018 Dec;10(12):7055-7063. doi: 10.21037/jtd.2018.11.89. Review.

2.

Upper Airway Cell Transcriptomics Identify a Major New Immunological Phenotype with Strong Clinical Correlates in Young Children with Acute Wheezing.

Khoo SK, Read J, Franks K, Zhang G, Bizzintino J, Coleman L, McCrae C, Öberg L, Troy NM, Prastanti F, Everard J, Oo S, Borland ML, Maciewicz RA, Le Souëf PN, Laing IA, Bosco A.

J Immunol. 2019 Mar 15;202(6):1845-1858. doi: 10.4049/jimmunol.1800178. Epub 2019 Feb 11.

PMID:
30745463
3.

Surgery or radiotherapy for stage I lung cancer? An intention to treat analysis.

Spencer KL, Kennedy MPT, Lummis KL, Ellames DAB, Snee M, Brunelli A, Franks K, Callister MEJ.

Eur Respir J. 2019 Jan 11. pii: 1801568. doi: 10.1183/13993003.01568-2018. [Epub ahead of print]

PMID:
30635294
4.

Minute ventilation-to-carbon dioxide slope is associated with postoperative survival after anatomical lung resection.

Miyazaki T, Callister MEJ, Franks K, Dinesh P, Nagayasu T, Brunelli A.

Lung Cancer. 2018 Nov;125:218-222. doi: 10.1016/j.lungcan.2018.10.003. Epub 2018 Oct 4.

PMID:
30429023
5.

Recurrent cortical circuits implement concentration-invariant odor coding.

Bolding KA, Franks KM.

Science. 2018 Sep 14;361(6407). pii: eaat6904. doi: 10.1126/science.aat6904.

PMID:
30213885
6.

EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC).

Pompili C, Koller M, Velikova G, Franks K, Absolom K, Callister M, Robson J, Imperatori A, Brunelli A.

Lung Cancer. 2018 Sep;123:149-154. doi: 10.1016/j.lungcan.2018.07.021. Epub 2018 Jul 17.

PMID:
30089587
7.

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.

Holch P, Pini S, Henry AM, Davidson S, Routledge J, Brown J, Absolom K, Gilbert A, Franks K, Hulme C, Morris C, Velikova G; eRAPID radiotherapy work group.

Pilot Feasibility Stud. 2018 Jun 5;4:110. doi: 10.1186/s40814-018-0304-6. eCollection 2018.

8.

RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities.

Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, Bindoff A, Peterson GM.

Med J Aust. 2018 May 21;208(9):398-403. Epub 2018 May 14.

PMID:
29747564
9.

British Thoracic Society quality standards for the investigation and management of pulmonary nodules.

Baldwin D, Callister M, Akram A, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Pearson P, Subesinghe M, Waller D, Woolhouse I.

BMJ Open Respir Res. 2018 Apr 16;5(1):e000273. doi: 10.1136/bmjresp-2017-000273. eCollection 2018.

10.

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy: Reply to Ghafoor et al.

Hanna GG, McDonald F, Murray L, Harrow S, Landau D, Ahmed M, Franks KN.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):456. doi: 10.1016/j.clon.2018.03.012. Epub 2018 Apr 11. No abstract available.

PMID:
29655554
11.

A transformation from temporal to ensemble coding in a model of piriform cortex.

Stern M, Bolding KA, Abbott LF, Franks KM.

Elife. 2018 Mar 29;7. pii: e34831. doi: 10.7554/eLife.34831.

12.

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.

Ashton M, O'Rourke N, Macleod N, Laird B, Stobo J, Kelly C, Alexander L, Franks K, Moore K, Currie S, Valentine R, Chalmers AJ.

Clin Transl Radiat Oncol. 2017 Nov 21;8:45-49. doi: 10.1016/j.ctro.2017.11.004. eCollection 2018 Jan.

13.

Older Adults' Experiences with Audiovisual Virtual Reality: Perceived Usefulness and Other Factors Influencing Technology Acceptance.

Roberts AR, De Schutter B, Franks K, Radina ME.

Clin Gerontol. 2019 Jan-Feb;42(1):27-33. doi: 10.1080/07317115.2018.1442380. Epub 2018 Mar 5.

PMID:
29505343
14.

Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?

Jones CM, Brunelli A, Callister ME, Franks KN.

Curr Surg Rep. 2018;6(2):5. doi: 10.1007/s40137-018-0202-0. Epub 2018 Feb 8. Review.

15.

Effectiveness of Respiratory-gated Positron Emission Tomography/Computed Tomography for Radiotherapy Planning in Patients with Lung Carcinoma - A Systematic Review.

Frood R, Prestwich R, Tsoumpas C, Murray P, Franks K, Scarsbrook A.

Clin Oncol (R Coll Radiol). 2018 Apr;30(4):225-232. doi: 10.1016/j.clon.2018.01.005. Epub 2018 Feb 1.

16.

Learning: Plasticity without Stabilization in Olfactory Cortex.

Nagappan S, Franks KM.

Curr Biol. 2018 Jan 8;28(1):R23-R25. doi: 10.1016/j.cub.2017.11.010.

17.

Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.

Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW Jr, Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GMM, Palma DA.

Pract Radiat Oncol. 2018 Mar - Apr;8(2):e71-e78. doi: 10.1016/j.prro.2017.10.008. Epub 2017 Dec 30.

PMID:
29291965
18.

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits.

Rulach R, Hanna GG, Franks K, McAleese J, Harrow S.

Clin Oncol (R Coll Radiol). 2018 Feb;30(2):101-109. doi: 10.1016/j.clon.2017.11.003. Epub 2017 Dec 6. Review.

PMID:
29223641
19.

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy.

Hanna GG, Murray L, Patel R, Jain S, Aitken KL, Franks KN, van As N, Tree A, Hatfield P, Harrow S, McDonald F, Ahmed M, Saran FH, Webster GJ, Khoo V, Landau D, Eaton DJ, Hawkins MA.

Clin Oncol (R Coll Radiol). 2018 Jan;30(1):5-14. doi: 10.1016/j.clon.2017.09.007. Epub 2017 Oct 13.

20.

Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).

Pompili C, Franks KN, Brunelli A, Hussain YS, Holch P, Callister ME, Robson JM, Papagiannopoulos K, Velikova G.

J Thorac Dis. 2017 Aug;9(8):2703-2713. doi: 10.21037/jtd.2017.07.35.

21.

Odor identity coding by distributed ensembles of neurons in the mouse olfactory cortex.

Roland B, Deneux T, Franks KM, Bathellier B, Fleischmann A.

Elife. 2017 May 10;6. pii: e26337. doi: 10.7554/eLife.26337.

22.

Complementary codes for odor identity and intensity in olfactory cortex.

Bolding KA, Franks KM.

Elife. 2017 Apr 5;6. pii: e22630. doi: 10.7554/eLife.22630.

23.

Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

Holch P, Henry AM, Davidson S, Gilbert A, Routledge J, Shearsmith L, Franks K, Ingleson E, Albutt A, Velikova G.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):495-510. doi: 10.1016/j.ijrobp.2016.11.008. Epub 2016 Nov 18. Review.

24.

Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer.

Pompili C, Velikova G, White J, Callister M, Robson J, Dixon S, Franks K, Brunelli A.

Eur J Cardiothorac Surg. 2017 Mar 1;51(3):526-531. doi: 10.1093/ejcts/ezw363.

26.
27.

A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.

Murray P, Franks K, Hanna GG.

Br J Radiol. 2017 Mar;90(1071):20160732. doi: 10.1259/bjr.20160732. Epub 2017 Feb 17. Review.

28.

Massive normalization of olfactory bulb output in mice with a 'monoclonal nose'.

Roland B, Jordan R, Sosulski DL, Diodato A, Fukunaga I, Wickersham I, Franks KM, Schaefer AT, Fleischmann A.

Elife. 2016 May 13;5. pii: e16335. doi: 10.7554/eLife.16335.

29.

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study.

Haslett K, Franks K, Hanna GG, Harden S, Hatton M, Harrow S, McDonald F, Ashcroft L, Falk S, Groom N, Harris C, McCloskey P, Whitehurst P, Bayman N, Faivre-Finn C.

BMJ Open. 2016 Apr 15;6(4):e010457. doi: 10.1136/bmjopen-2015-010457. Erratum in: BMJ Open. 2016 Jul 18;6(7):e010457corr1.

30.

Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.

Murray L, Karakaya E, Hinsley S, Naisbitt M, Lilley J, Snee M, Clarke K, Musunuru HB, Ramasamy S, Turner R, Franks K.

Br J Radiol. 2016;89(1058):20150628. doi: 10.1259/bjr.20150628.

31.

Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis.

Franks KH, Chuah MI, King AE, Vickers JC.

Front Aging Neurosci. 2015 Dec 15;7:234. doi: 10.3389/fnagi.2015.00234. eCollection 2015. Review.

32.

I Want It All and I Want It Now: How a Neural Circuit Encodes Odor with Speed and Accuracy.

Franks KM.

Neuron. 2015 Dec 2;88(5):852-854. doi: 10.1016/j.neuron.2015.11.016.

33.

Effectiveness of professional oral health care intervention on the oral health of residents with dementia in residential aged care facilities: a systematic review protocol.

Yi Mohammadi JJ, Franks K, Hines S.

JBI Database System Rev Implement Rep. 2015 Oct;13(10):110-22. doi: 10.11124/jbisrir-2015-2330.

PMID:
26571287
34.

Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.

Murray L, Ramasamy S, Lilley J, Snee M, Clarke K, Musunuru HB, Needham A, Turner R, Sangha V, Flatley M, Franks K.

Clin Oncol (R Coll Radiol). 2016 Jan;28(1):4-12. doi: 10.1016/j.clon.2015.09.007. Epub 2015 Oct 21.

PMID:
26474546
35.

Pitfalls and Challenges to Consider before Setting up a Lung Cancer Intensity-modulated Radiotherapy Service: A Review of the Reported Clinical Experience.

Shrimali RK, Mahata A, Reddy GD, Franks KN, Chatterjee S.

Clin Oncol (R Coll Radiol). 2016 Mar;28(3):185-97. doi: 10.1016/j.clon.2015.08.002. Epub 2015 Aug 29. Review.

PMID:
26329504
36.

Recurrent rhinovirus detections in children following a rhinovirus-induced wheezing exacerbation: A retrospective study.

Halmø Hürdum S, Zhang G, Khoo SK, Bizzintino J, Franks KM, Lindsay K, Keil AD, Cox DW, Goldblatt J, Bochkov YA, Gern J, Ulrik CS, Souëf PN, Laing IA.

Int J Pediatr Child Health. 2015 Aug;3(1):10-18. doi: 10.12974/2311-8687.2015.03.01.2.

37.

British Thoracic Society guidelines for the investigation and management of pulmonary nodules.

Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Prokop M, Rodger K, Subesinghe M, Waller D, Woolhouse I; British Thoracic Society Pulmonary Nodule Guideline Development Group; British Thoracic Society Standards of Care Committee.

Thorax. 2015 Aug;70 Suppl 2:ii1-ii54. doi: 10.1136/thoraxjnl-2015-207168. No abstract available. Erratum in: Thorax. 2015 Dec;70(12):1188.

PMID:
26082159
38.

The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy.

Henry AM, Rodda SL, Mason M, Musunuru H, Al-Qaisieh B, Bownes P, Smith J, Franks K, Carey B, Bottomley D.

Clin Oncol (R Coll Radiol). 2015 Jul;27(7):382-6. doi: 10.1016/j.clon.2015.03.004. Epub 2015 Mar 21.

39.

Stereotactic ablative body radiotherapy for lung cancer.

Franks KN, Jain P, Snee MP.

Clin Oncol (R Coll Radiol). 2015 May;27(5):280-9. doi: 10.1016/j.clon.2015.01.006. Epub 2015 Mar 4.

PMID:
25746732
40.

Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.

Murray LJ, Thompson CM, Lilley J, Cosgrove V, Franks K, Sebag-Montefiore D, Henry AM.

Phys Med Biol. 2015 Feb 7;60(3):1237-57. doi: 10.1088/0031-9155/60/3/1237. Epub 2015 Jan 15.

41.

KIBRA gene polymorphism has no association with verbal or visual episodic memory performance.

Franks KH, Summers MJ, Vickers JC.

Front Aging Neurosci. 2014 Oct 8;6:270. doi: 10.3389/fnagi.2014.00270. eCollection 2014.

42.

Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.

Robson JM, Vaidyanathan S, Cheyne L, Snee M, Franks K, Callister ME.

Clin Lung Cancer. 2014 Nov;15(6):466-9. doi: 10.1016/j.cllc.2014.07.006. Epub 2014 Aug 15.

PMID:
25220208
43.

Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.

Murray LJ, Lilley J, Thompson CM, Cosgrove V, Mason J, Sykes J, Franks K, Sebag-Montefiore D, Henry AM.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):406-15. doi: 10.1016/j.ijrobp.2014.01.042. Epub 2014 Mar 28.

44.

Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

Musunuru H, Mason M, Murray L, Al-Qaisieh B, Bownes P, Smith J, Franks K, Carey B, Bottomley D, Henry AM.

Clin Oncol (R Coll Radiol). 2014 Apr;26(4):210-5. doi: 10.1016/j.clon.2014.01.006. Epub 2014 Feb 6.

PMID:
24507938
45.

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT).

Murray LJ, Cosgrove V, Lilley J, Sykes J, Thompson CM, Franks K, Sebag-Montefiore D, Henry AM.

Radiother Oncol. 2014 Feb;110(2):298-302. doi: 10.1016/j.radonc.2013.10.036. Epub 2013 Dec 11.

46.

Implementation of image-guided radiotherapy.

Franks KN, McNair HA.

Clin Oncol (R Coll Radiol). 2012 Nov;24(9):625-6. doi: 10.1016/j.clon.2012.06.002. Epub 2012 Jul 15. No abstract available.

PMID:
22801517
47.

Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?

Clarke K, Taremi M, Dahele M, Freeman M, Fung S, Franks K, Bezjak A, Brade A, Cho J, Hope A, Sun A.

Radiother Oncol. 2012 Jul;104(1):62-6. doi: 10.1016/j.radonc.2012.04.019. Epub 2012 Jun 9.

PMID:
22682749
48.

Mitral cells in the olfactory bulb are mainly excited through a multistep signaling path.

Gire DH, Franks KM, Zak JD, Tanaka KF, Whitesell JD, Mulligan AA, Hen R, Schoppa NE.

J Neurosci. 2012 Feb 29;32(9):2964-75. doi: 10.1523/JNEUROSCI.5580-11.2012.

49.

Effects of Motorized vs Non-Motorized Treadmill Training on Hamstring/Quadriceps Strength Ratios.

Franks KA, Brown LE, Coburn JW, Kersey RD, Bottaro M.

J Sports Sci Med. 2012 Mar 1;11(1):71-6. eCollection 2012.

50.

Incidence and survival of rare urogenital cancers in Europe.

Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M, Franks KN; RARECARE working group.

Eur J Cancer. 2012 Mar;48(4):456-64. doi: 10.1016/j.ejca.2011.10.031. Epub 2011 Nov 24.

PMID:
22119351

Supplemental Content

Loading ...
Support Center